ESGO Prevention Committee opinion: is a single dose of HPV vaccine good enough?

Currently licensed human papillomavirus (HPV) vaccines are very effective against cervical cancer and pre-cancer and probably also effective against five additional HPV-related cancers with no available screening strategies.[1][1] Antibodies triggered by the vaccine are different from antibodies

Авторы
Kamani M.O.3, 4 , Kyrgiou Maria5, 6, 7, 8 , Joura Elmar9, 10 , Zapardiel Ignacio11, 12 , Grigore Mihaela3, 13 , Arbyn Marc 14, 15, 16, 17 , Preti Mario18, 19 , Planchamp François , Gultekin Murat3, 4
Журнал
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Издательство
LIPPINCOTT WILLIAMS & WILKINS
Номер выпуска
4
Язык
Английский
Страницы
462-464
Статус
Опубликовано
Том
33
Год
2023
Организации
  • 1 Department of Obstetrics and Gynecology
  • 2 Hacettepe University Faculty of Medicine
  • 3 IRDB, Department of MDR – Surgery & Cancer
  • 4 Imperial College Healthcare NHS Trust
  • 5 Imperial College London
  • 6 West London Gynaecological Cancer Centre
  • 7 Department of Gynecology and Gynecologic Oncology, Comprehensive Cancer Center
  • 8 Medical University of Vienna
  • 9 Gynecologic Oncology
  • 10 La Paz University Hospital
  • 11 Grigore T Popa University of Medicine and Pharmacy Faculty of Medicine
  • 12 Belgian Cancer Centre Sciensano
  • 13 Department of Human Structure and Repair
  • 14 Ghent University Faculty of Medicine and Health Sciences
  • 15 Unit of Cancer Epidemiology
  • 16 Department of Obstetrics and Gynaecology
  • 17 Università degli Studi di Torino
  • 18 Clinical Research Unit
  • 19 Institut Bergonie
Цитировать
ГОСТ MLA RIS BibTex
Поделиться

Другие записи